How can shared decision-making support heart failure care when chronic hyperkalemia complicates GDMT? Join Dr. Savarese as he explores patient priorities, potassium management, and oral potassium binders: ow.ly/1Tl05100bWq #HeartFailure #Hyperkalemia

Are you routinely asking patients on hemodialysis about itch? Drs. Burton and Sánchez discuss the burden of CKD-aP, its impact on quality of life, and strategies for identification and management. Explore the full discussion: ow.ly/GjKq50ZYYvP #Nephrology #CKDaP

Proteinuria, blood pressure, and eGFR remain important in IgAN, but could emerging biomarkers offer additional insights? Explore research on Gd-IgA1, complement biomarkers, and urinary soluble CD163: ow.ly/FU0l50ZUAfW #IgAN #Nephrology

How can potassium binders help maintain RAASi therapy in patients with CKD, heart failure, and hyperkalemia? Drs. Ellie Kelepouris and Nihar Desai review guideline recommendations, clinical evidence, and treatment considerations: ow.ly/lgMS50ZFmOo #CKD #HeartFailure #CME

How can clinicians identify CKD-associated pruritus earlier? Drs. Jim Burton and Emilio Sánchez discuss proactive assessment, symptom severity, quality-of-life impact, and management considerations: ow.ly/aWaw50ZFmyV #CKD #Pruritus #CME

How can clinicians look beyond clinical scales when monitoring young patients with generalized myasthenia gravis? Explore why symptoms across the day, family observations, school experiences, and social functioning can help inform care: ow.ly/psFz50Zy9lV #MyastheniaGravis

Emerging research suggests inflammation may play a meaningful role in CKD-associated pruritus. Investigators observed associations between inflammatory biomarkers and itch severity. Explore the data: ow.ly/WTSA50ZtwVZ #CKDaP #Nephrology #Research

Hyperkalemia concerns shouldn't stand in the way of guideline-directed therapy for patients with CKD and heart failure. Learn how long-term potassium management strategies can support optimal treatment while reducing risk: ow.ly/zptw50Zq40F #Nephrology

What are the limitations of current therapies for IgAN? How can we do better for our patients with IgA nephropathy? Tune in to hear Drs. Jonathan Barratt and Annette Bruchfeld discuss current and future directions in treatment: ow.ly/rE4850ZmwzN #IgAN

Hyperkalemia remains a key consideration when treating patients with heart failure and CKD. Experts share strategies for managing potassium while maintaining guideline-directed medical therapy: ow.ly/k5E150ZkHt1

Up to 50–70% of patients with CKD may have iron deficiency, yet it often goes unrecognized. Are you routinely assessing ferritin and TSAT in your patients with CKD? Learn more: ow.ly/rq4x50ZfrFs #CKD #IronDeficiency

CKD-associated pruritus can affect far more than the skin. Sleep, mood, and daily activities may all be impacted and the burden increases with itch severity. Learn why proactive assessment matters: globalkidneyacademy.org/u/19… #Nephrology #CKD #Hemodialysis

Hyperkalemia is a major concern in patients with CKD and heart failure. How can clinicians manage potassium levels without compromising guideline-directed therapy? Explore expert insights: globalkidneyacademy.org/u/19… #Hyperkalemia #CKD #HF

How do you help patients with IgA nephropathy move beyond fear of kidney failure and toward informed decision-making? Explore practical communication strategies for discussing prognosis, treatment options, and patient priorities in #IgAN: globalkidneyacademy.org/u/18… #Nephrology

CKD-associated pruritus is more than dry skin alone. Explore the roles of inflammation, neuropathy, uremic toxins, and opioid receptor imbalance in CKD-aP pathophysiology: ow.ly/4EQI50Z4qQW

What role does the complement pathway play in ANCA-associated vasculitis? Explore how C5a-mediated neutrophil activation contributes to inflammation, vascular injury, and kidney damage in AAV: globalkidneyacademy.org/u/18… #AAV #Nephrology

Proteinuria below 1 g/day may still place patients with IgA nephropathy at risk for kidney failure. How are the 2025 #KDIGO guidelines reshaping treatment goals? Hear experts discuss earlier intervention and updated proteinuria targets: globalkidneyacademy.org/u/18… #Nephrology #IgAN

Today is #IgANAwarenessDay! Take a deeper look at IgA nephropathy through expert-led programs exploring KDIGO recommendations, proteinuria reduction strategies, shared decision-making, and more: globalkidneyacademy.org/dise… #Nephrology #IgAN #KidneyHealth

How do you manage #hyperkalemia without compromising guideline-directed medical therapy in #heartfailure? A recent case highlights the challenge: stopping MRAs may normalize potassium but can worsen HF symptoms. Learn how potassium binders can help: globalkidneyacademy.org/u/18…

Are antihistamines addressing the root cause of itch in CKD-aP? Emerging evidence shows CKD-associated pruritus is driven by non-histaminergic pathways, raising questions about traditional approaches. Explore the evolving science: globalkidneyacademy.org/u/18… #Nephrology #CKDaP